Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.46 |
| ▸ | NAAA | Q02083 | 1/20 | 0.35 |
| ▸ | OTUD7B | Q6GQQ9 | 3/20 | 0.33 |
| ▸ | USP30 | Q70CQ3 | 1/20 | 0.31 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | ICMT | O60725 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL332890 | 0.88 | ALOX5 (0.38) | ALOX5NAAAOTUD7B | |
| SCHEMBL3660567 | 0.84 | ALOX5 (0.46) | ALOX5NAAAOTUD7BUSP30CD274 | |
| SCHEMBL332778 | 0.81 | ALOX5 (0.67) | ALOX5USP30CD274 | |
| SCHEMBL332920 | 0.76 | ALOX5 (0.36) | ALOX5NAAAOTUD7BUSP30ICMT | |
| SCHEMBL332725 | 0.75 | ALOX5 (0.53) | ALOX5NAAAOTUD7BUSP30CD274 | |
| SCHEMBL12156883 | 0.73 | ALOX5 (0.38) | ALOX5NAAAOTUD7B | |
| SCHEMBL332739 | 0.73 | ALOX5 (0.38) | ALOX5NAAAOTUD7B | |
| SCHEMBL332455 | 0.72 | ALOX5 (0.55) | ALOX5CD274 | |
| SCHEMBL3655644 | 0.72 | ALOX5 (0.42) | ALOX5NAAAOTUD7BUSP30 | |
| SCHEMBL332825 | 0.71 | ALOX5 (0.49) | ALOX5NAAAICMT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8097733-B2 | Pyrazole derivatives as 5-LO-inhibitors | PFIZER INC. (US) | 2012-01-17 | — | — | US | disclosed |
| US-20090227634-A1 | Pyrazole Derivatives as 5-LO-Inhibitors | PFIZER INC. | 2009-09-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090227634-A1 | Pyrazole Derivatives as 5-LO-Inhibitors | ALOX5, ALOX15, CYP3A5 | ALOX5 1/4885NAAA 2503/4885OTUD7B 3963/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.